A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus01)
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sun Yat-sen University
Taiho Oncology, Inc.
Actuate Therapeutics Inc.
National Cancer Institute (NCI)
Novartis
Eli Lilly and Company
Roswell Park Cancer Institute
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Akeso
Alliance for Clinical Trials in Oncology
Merck Sharp & Dohme LLC
OncoSil Medical Limited
Alliance for Clinical Trials in Oncology
University of Wisconsin, Madison
OHSU Knight Cancer Institute
Children's Oncology Group
Revolution Medicines, Inc.
University Health Network, Toronto
Institut du Cancer de Montpellier - Val d'Aurelle
Thomas Jefferson University
Akeso
Bristol-Myers Squibb
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
Pfizer
Sun Yat-sen University
Toray Industries, Inc
University of Cincinnati
Gruppo Oncologico del Nord-Ovest
CARsgen Therapeutics Co., Ltd.
University of Campania Luigi Vanvitelli
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
UNICANCER
Emory University
Helsinki University Central Hospital
Australasian Gastro-Intestinal Trials Group
Oslo University Hospital
Ono Pharmaceutical Co. Ltd
National Cancer Institute (NCI)
Academic and Community Cancer Research United
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Rutgers, The State University of New Jersey
University of Birmingham